TCR Analyses of Two Vast and Shared Melanoma Antigen-Specific T Cell Repertoires: Common and Specific Features
Among Immunotherapeutic approaches for cancer treatment, the adoptive transfer of antigen specific T cells is still a relevant approach, that could have higher efficacy when further combined with immune check-point blockade. A high number of adoptive transfer trials have been performed in metastatic...
Main Authors: | Sylvain Simon, Zhong Wu, J. Cruard, Virginie Vignard, Agnes Fortun, Amir Khammari, Brigitte Dreno, Francois Lang, Samuel J. Rulli, Nathalie Labarriere |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.01962/full |
Similar Items
-
MELOE-1 antigen contains multiple HLA class II T cell epitopes recognized by Th1 CD4+ T cells from melanoma patients.
by: Mathilde Bobinet, et al.
Published: (2012-01-01) -
Overexpression of meloe gene in melanomas is controlled both by specific transcription factors and hypomethylation.
by: Mathilde Bobinet, et al.
Published: (2013-01-01) -
The melanoma antigens MELOE-1 and MELOE-2 are translated from a bona fide polycistronic mRNA containing functional IRES sequences.
by: Delphine Carbonnelle, et al.
Published: (2013-01-01) -
PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
by: Sylvain Simon, et al.
Published: (2018-01-01) -
Serum soluble HLA-E in melanoma: a new potential immune-related marker in cancer.
by: Mathilde Allard, et al.
Published: (2011-01-01)